Nokia, Pfizer, BofA, Zynga in High Stock Volume Demand Feb 2nd

Nokia Corporation (NYSE:NOK): A large increase in sales of Apple’s (NASDAQ:AAPL) iPhone caused the company to jump to third place in worldwide mobile phone sales in Q4, up from fifth place previously, according to Cnet, which cited research firm IDC Apple, which had an 8.7% share of the worldwide market last quarter, now trails only Nokia (NYSE:NOK) and Samsung in mobile phone sales, the publication added.

Pfizer Inc. (NYSE:PFE): Mylan (NASDAQ:MYL) announced that its subsidiary Mylan Laboratories Ltd., formerly Matrix Laboratories Ltd, has received tentative approval from the U.S. FDA for its Abbreviated New Drug Application, or ANDA, for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg base. Atorvastatin Calcium is the generic equivalent to Pfizer’s Lipitor Tablets, indicated for the prevention of cardiovascular disease and hypercholesterolemia. Lipitor had U.S. sales of $8.2B for the twelve months ending Dec. 31, 2011, according to IMS Health.

Bank of America Corp (NYSE:BAC): Sheila Bair on CNBC: Greek debt default would not be major event for U.S. banks like Bank of America.

SandRidge Energy Inc. (NYSE:SD): Tudor Pickering downgraded SandRidge based on its acquisition of Driller Dynamics Resources and the expected multiple compression, strategy shift, and NAV dilution.

Zynga Inc (NASDAQ:ZNGA): Piper Jaffray believes Facebook’s preliminary prospectus provides a positive read through to Zynga. The firm sees an expanding addressable market opportunity for Zynga due to Facebook’s growing user base and reiterates an Overweight rating on the stock with an $11 price target.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at